Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of RM-131 on gastric emptying,
gastroparesis symptoms, and the safety and tolerability of RM-131 compared to placebo in
patients with Type 1 and Type 2 diabetes mellitus and gastroparesis. The study is designed to
evaluate the efficacy and safety of multiple dose regimens of RM-131. Study drug (RM-131 and
placebo) will be administered subcutaneously in a blinded fashion.